These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 19390236)

  • 1. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K; Gotoh M
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
    Yuta A; Ogihara H; Miyamoto Y; Takeuchi K; Okubo K
    Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
    Fujimura T; Okamoto Y
    Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
    Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
    Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present situation of cedar pollinosis in Japan and its immune responses.
    Okamoto Y; Horiguchi S; Yamamoto H; Yonekura S; Hanazawa T
    Allergol Int; 2009 Jun; 58(2):155-62. PubMed ID: 19307773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to immunotherapies for Japanese cedar pollinosis.
    Sakaguchi M; Hirahara K; Fujimura T; Toda M
    Auris Nasus Larynx; 2011 Aug; 38(4):431-8. PubMed ID: 21227607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
    Osada T; Okano M
    Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of sublingual grass pollen immunotherapy after anaphylaxis.
    Nichani JR; de Carpentier J
    J Laryngol Otol; 2009 Jun; 123(6):683-4. PubMed ID: 18501039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
    Tofukuji S; Ishida S; Katayama K
    Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
    Pokladnikova J; Krcmova I; Vlcek J
    Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen immunotherapy for allergic rhinitis.
    Okubo K; Gotoh M
    J Nippon Med Sch; 2010 Dec; 77(6):285-9. PubMed ID: 21206140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.